Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Bernard Hirschel
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Living Beings
Concepts & Ideas
Geographic Areas
Sign-in to see full Profile
Network (preview)
69
Furrer, Hansjakob
65
Bernasconi, Enos
54
Perrin, Luc
49
Battegay, Manuel
41
Yerly, Sabine
40
Weber, Rainer
37
Vernazza, Pietro
34
Rickenbach, Martin
33
Opravil, Milos
31
Günthard, Huldrych
30
Cavassini, Matthias
29
ledergerber, bruno
28
Telenti, Amalio
26
Bucher, Heiner
23
Flepp, Markus
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Bernard Hirschel (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Calmy Alexandra; Fux Christoph A; Norris Richard; Vallier Nathalie; Delhumeau Cécile; Samaras Katherine; Hesse Karl; Hirschel Bernard; Cooper David A; Carr Andrew
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
The Journal of infectious diseases 2009;200(11):1746-54.
-
2009: Rauch Andri; James Ian; Pfafferott Katja; Nolan David; Klenerman Paul; Cheng Wendy; Mollison Lindsay; McCaughan Geoff; Shackel Nick; Jeffrey Gary P; Baker Ross; Freitas Elizabeth; Humphreys Isla; Furrer Hansjakob; Günthard Huldrych F; Hirschel Bernard; Mallal Simon; John Mina; Lucas Michaela; Barnes Eleanor; Gaudieri Silvana
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
Hepatology (Baltimore, Md.) 2009;50(4):1017-29.
-
2009: Combescure Christophe; Vallier N; Ledergerber B; Cavassini M; Furrer H; Rauch A; Battegay M; Bernasconi E; Vernazza P; Hirschel B;
How reliable is an undetectable viral load?
HIV medicine 2009;10(8):470-6.
-
2009: Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
HIV medicine 2009;10(7):407-16.
-
2009: Gayet-Ageron A; Ninet B; Toutous-Trellu L; Lautenschlager S; Furrer H; Piguet V; Schrenzel J; Hirschel B
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples.
Sexually transmitted infections 2009;85(4):264-9.
-
2009: Elzi Luigia; Kaufmann Gilbert; Weber Rainer; Fux Christoph A; Cavassini Matthias; Hirschel Bernard; Vernazza Pietro; Bernasconi Enos; Battegay Manuel;
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.
HIV clinical trials 2009;10(4):207-14.
-
2009: Yerly Sabine; Junier Thomas; Gayet-Ageron Angèle; Amari Emmanuelle Boffi El; von Wyl Viktor; Günthard Huldrych F; Hirschel Bernard; Zdobnov Evgeny; Kaiser Laurent;
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.
AIDS (London, England) 2009;23(11):1415-23.
-
2009: Young Jim; Glass Tracy R; Bernasconi Enos; Rickenbach Martin; Furrer Hansjakob; Hirschel Bernard; Tarr Philip E; Vernazza Pietro; Battegay Manuel; Bucher Heiner C;
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
Journal of clinical epidemiology 2009;62(6):632-41.
-
2009: Calmy Alexandra; Gayet-Ageron Angele; Montecucco Fabrizio; Nguyen Alain; Mach Francois; Burger Fabienne; Ubolyam Sasiwimol; Carr Andrew; Ruxungtham Kiat; Hirschel Bernard; Ananworanich Jintanat;
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.
AIDS (London, England) 2009;23(8):929-39.
-
2009: Hirschel Bernard; Flanigan Timothy
Is it smart to continue to study treatment interruptions?
AIDS (London, England) 2009;23(7):757-9.
-
2009: von Wyl Viktor; Yerly Sabine; Bürgisser Philippe; Klimkait Thomas; Battegay Manuel; Bernasconi Enos; Cavassini Matthias; Furrer Hansjakob; Hirschel Bernard; Vernazza Pietro L; Francioli Patrick; Bonhoeffer Sebastian; Ledergerber Bruno; Günthard Huldrych F; Swiss HIV Cohort Study
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):979-87.
-
2009: El Amari Emmanuelle Boffi; Hirschel Bernard
[HIV-AIDS 2008: the year in review]
Revue médicale suisse 2009;5(185):69-71.
-
2009: Young Jim; Bucher Heiner C; Guenthard Huldrych F; Rickenbach Martin; Fux Christoph A; Hirschel Bernard; Cavassini Matthias; Vernazza Pietro; Bernasconi Enos; Battegay Manuel;
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.
Antiviral therapy 2009;14(6):771-9.
-
2009: Conen Anna; Fehr Jan; Glass Tracy R; Furrer Hansjakob; Weber Rainer; Vernazza Pietro; Hirschel Bernard; Cavassini Matthias; Bernasconi Enos; Bucher Heiner C; Battegay Manuel;
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
Antiviral therapy 2009;14(3):349-57.
-
2009: Calmy Alexandra; Hirschel Bernard; Cooper David A; Carr Andrew
A new era of antiretroviral drug toxicity.
Antiviral therapy 2009;14(2):165-79.
-
2008: Vernazza Pietro; Hirschel Bernard; Bernasconi Enos; Flepp Markus
HIV transmission under highly active antiretroviral therapy.
Lancet 2008;372(9652):1806-7; author reply 1807.
-
2008: Keiser Olivia; Gayet-Ageron Angèle; Rudin Christoph; Brinkhof Martin W G; Gremlich Erika; Wunder Dorothea; Drack Gero; Hirschel Bernard; de Tejada Begoña Martinez;
Antiretroviral treatment during pregnancy.
AIDS (London, England) 2008;22(17):2323-30.
-
2008: Fox Zoe; Phillips Andrew; Cohen Cal; Neuhaus Jacquie; Baxter John; Emery Sean; Hirschel Bernard; Hullsiek Kathy Huppler; Stephan Christoph; Lundgren Jens;
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
AIDS (London, England) 2008;22(17):2279-89.
-
2008: Joos Beda; Fischer Marek; Kuster Herbert; Pillai Satish K; Wong Joseph K; Böni Jürg; Hirschel Bernard; Weber Rainer; Trkola Alexandra; Günthard Huldrych F;
HIV rebounds from latently infected cells, rather than from continuing low-level replication.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(43):16725-30.
-
2008: Fätkenheuer Gerd; Nelson Mark; Lazzarin Adriano; Konourina Irina; Hoepelman Andy I M; Lampiris Harry; Hirschel Bernard; Tebas Pablo; Raffi François; Trottier Benoit; Bellos Nicholaos; Saag Michael; Cooper David A; Westby Mike; Tawadrous Margaret; Sullivan John F; Ridgway Caroline; Dunne Michael W; Felstead Steve; Mayer Howard; van der Ryst Elna;
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
The New England journal of medicine 2008;359(14):1442-55.
-
2008: Khanna Nina; Opravil Milos; Furrer Hansjakob; Cavassini Matthias; Vernazza Pietro; Bernasconi Enos; Weber Rainer; Hirschel Bernard; Battegay Manuel; Kaufmann Gilbert R;
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1093-101.
-
2008: Mangclaviraj Somsamorn; Kerr Stephen J; Chaithongwongwatthana Surasith; Ananworanich Jintanat; Hirschel Bernard; Emery Sean; Cooper David A; Chotnopparatpattara Pichai; Ruxrungtham Kiat; Phanuphak Praphan
Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting.
International journal of STD & AIDS 2008;19(8):529-32.
-
2008: Wunder D M; Fux C A; Bersinger N A; Mueller N J; Hirschel B; Cavassini M; Elzi L; Schmid P; Bernasconi E; Mueller B; Furrer H;
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study.
HIV medicine 2008;9(6):427-32.
-
2008: Wolbers M; Bucher H C; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
HIV medicine 2008;9(6):397-405.
-
2008: Vo Thi Tuyet Nhung; Ledergerber Bruno; Keiser Olivia; Hirschel Bernard; Furrer Hansjakob; Battegay Manuel; Cavassini Matthias; Bernasconi Enos; Vernazza Pietro; Weber Rainer;
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.
The Journal of infectious diseases 2008;197(12):1685-94.
-
2008: Rauch Andri; Nolan David; Furrer Hansjakob; McKinnon Elizabeth; John Mina; Mallal Simon; Gaudieri Silvana; Günthard Huldrych F; Schmid Patrick; Battegay Manuel; Hirschel Bernard; Telenti Amalio; James Ian;
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1921-5.
-
2008: Ananworanich Jintanat; Nuesch Reto; Côté Hélène C F; Kerr Stephen J; Hill Andrew; Jupimai Thidarat; Laopraynak Naphassanant; Saenawat Sukontha; Ruxrungtham Kiat; Hirschel Bernard
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.
The Journal of antimicrobial chemotherapy 2008;61(6):1340-3.
-
2008: El Amari Emmanuelle Boffi; Toutous-Trellu Laurence; Gayet-Ageron Angèle; Baumann Michele; Cathomas Gieri; Steffen Ingrid; Erb Peter; Mueller Nicolas J; Furrer Hansjakob; Cavassini Matthias; Vernazza Pietro; Hirsch Hans H; Bernasconi Enos; Hirschel Bernard;
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
AIDS (London, England) 2008;22(9):1019-28.
-
2008: Hirschel Bernard; Calmy Alexandra
Initial treatment for HIV infection--an embarrassment of riches.
The New England journal of medicine 2008;358(20):2170-2.
-
2008: von Wyl Viktor; Yerly Sabine; Böni Jürg; Bürgisser Philippe; Klimkait Thomas; Battegay Manuel; Bernasconi Enos; Cavassini Matthias; Furrer Hansjakob; Hirschel Bernard; Vernazza Pietro L; Rickenbach Martin; Ledergerber Bruno; Günthard Huldrych F;
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1299-309.
-
2008: Hill Andrew; Hirschel Bernard; Katlama Christine
The Monark trial: where now for boosted protease inhibitor monotherapy?
AIDS (London, England) 2008;22(6):777-9.
-
2008: Ananworanich J; Pumpradit W; Apateerapong W; Siangphoe U; Saenawat S; Phanuphak P; Hirschel B
Preference for CD4-guided versus continuous HARRT in Thailand.
AIDS care 2008;20(3):327-30.
-
2008: Nguyen A; Calmy A; Schiffer V; Bernasconi E; Battegay M; Opravil M; Evison J-M; Tarr P E; Schmid P; Perneger T; Hirschel B;
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.
HIV medicine 2008;9(3):142-50.
-
2008: Hirschel Bernard
["The new Center will allow the professionalization of patient-oriented clinical research". Interview by Marina Casselyn, Michael Balavoine, Kiefer Bertrand]
Revue médicale suisse 2008;4(139):3-5.
-
2008: Nüesch Reto; Ananworanich Jintanat; Srasuebkul Preeyaporn; Chetchotisakd Ploenchan; Prasithsirikul Wisit; Klinbuayam Wirat; Mahanontharit Apicha; Jupimai Thidarat; Ruxrungtham Kiat; Hirschel Bernard
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
AIDS (London, England) 2008;22(1):152-4.
-
2008: Langford Simone; Gayet-Ageron Angele; Duncombe Chris; Jupimai Thidarat; Mahanontharit Apicha; Kiertiburanakul Sasisopin; Munsakul Warangkana; Ruxrungtham Kiat; Hirschel Bernard; Ananworanich Jintanat; Study Group Staccato
Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure.
The open virology journal 2008;2():69-73.
-
2008: Fux Christoph A; Rauch Andri; Simcock Mathew; Bucher Heiner C; Hirschel Bernard; Opravil Milos; Vernazza Pietro; Cavassini Matthias; Bernasconi Enos; Elzi Luigia; Furrer Hansjakob;
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
Antiviral therapy 2008;13(8):1077-82.
-
2008: Vernazza Pietro L; Hirschel Bernard
HIV transmission hunting--the chase for low risk events.
Antiviral therapy 2008;13(5):641-2.
-
2008: Ananworanich Jintanat; Gayet-Ageron Angele; Ruxrungtham Kiat; Chetchotisakd Ploenchan; Prasithsirikul Wisit; Kiertiburanakul Sasisopin; Munsakul Warangkana; Raksakulkarn Phitsonu; Tansuphasawadikul Somboon; LeBraz Michelle; Jupimai Thidarat; Ubolyam Sasiwimol; Schutz Malte; Hirschel Bernard;
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
Antiviral therapy 2008;13(3):375-80.
-
2008: Glass Tracy R; De Geest Sabina; Hirschel Bernard; Battegay Manuel; Furrer Hansjakob; Covassini Matthias; Vernazza Pietro L; Bernasconi Enos; Rickenboch Martin; Weber Rainer; Bucher Heiner C;
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
Antiviral therapy 2008;13(1):77-85.
-
2007: Giulieri Stefano; Schiffer Veronique; Yerly Sabine; Burgisser Philippe; Hirschel Bernard; Cavassini Matthias
The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load.
Archives of internal medicine 2007;167(22):2524-6.
-
2007: Wolbers Marcel; Opravil Milos; von Wyl Viktor; Hirschel Bernard; Furrer Hansjakob; Cavassini Matthias; Vernazza Pietro; Bernasconi Enos; Battegay Manuel; Yerly Sabine; Günthard Huldrych; Bucher Heiner C;
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
AIDS (London, England) 2007;21(16):2201-7.
-
2007: von Wyl Viktor; Yerly Sabine; Böni Jürg; Bürgisser Philippe; Klimkait Thomas; Battegay Manuel; Furrer Hansjakob; Telenti Amalio; Hirschel Bernard; Vernazza Pietro L; Bernasconi Enos; Rickenbach Martin; Perrin Luc; Ledergerber Bruno; Günthard Huldrych F;
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
Archives of internal medicine 2007;167(16):1782-90.
-
2007: Mocroft Amanda; Ledergerber Bruno; Zilmer Kai; Kirk Ole; Hirschel Bernard; Viard Jean-Paul; Reiss Peter; Francioli Patrick; Lazzarin Adriano; Machala Ladislav; Phillips Andrew N; Lundgren Jens D;
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
AIDS (London, England) 2007;21(14):1867-75.
-
2007: Arnedo Mireia; Taffé Patrick; Sahli Roland; Furrer Hansjakob; Hirschel Bernard; Elzi Luigia; Weber Rainer; Vernazza Pietro; Bernasconi Enos; Darioli Roger; Bergmann Sven; Beckmann Jacques S; Telenti Amalio; Tarr Philip E;
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Pharmacogenetics and genomics 2007;17(9):755-64.
-
2007: Boom J; Kösters E; Duncombe C; Kerr S; Hirschel B; Ruxrungtham K; de Mast Q; Kosalaraksa P; Ulbolyam S; Jupimai T; Ananworanich J;
Ferritin levels during structured treatment interruption of highly active antiretroviral therapy.
HIV medicine 2007;8(6):388-95.
-
2007: Calmy Alexandra; Hirschel Bernard; Cooper David A; Carr Andrew
Clinical update: adverse effects of antiretroviral therapy.
Lancet 2007;370(9581):12-4.
-
2007: Hirschel Bernard; Perneger Thomas
No patient left behind--better treatments for resistant HIV infection.
Lancet 2007;370(9581):3-5.
-
2007: Ledergerber Bruno; Furrer Hansjakob; Rickenbach Martin; Lehmann Roger; Elzi Luigia; Hirschel Bernard; Cavassini Matthias; Bernasconi Enos; Schmid Patrick; Egger Matthias; Weber Rainer;
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(1):111-9.
-
2007: Vernazza Pietro; Daneel Synøve; Schiffer Véronique; Decosterd Laurent; Fierz Walter; Klimkait Thomas; Hoffmann Matthias; Hirschel Bernard
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.
AIDS (London, England) 2007;21(10):1309-15.
-
2007: Frater A J; Brown H; Oxenius A; Günthard H F; Hirschel B; Robinson N; Leslie A J; Payne R; Crawford H; Prendergast A; Brander C; Kiepiela P; Walker B D; Goulder P J R; McLean A; Phillips R E
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.
Journal of virology 2007;81(12):6742-51.
-
2007: Gayet-Ageron Angele; Ananworanich Jintanat; Jupimai Thidarat; Chetchotisakd Ploenchan; Prasithsirikul Wisit; Ubolyam Sasiwimol; Le Braz Michelle; Ruxrungtham Kiat; Rooney James F; Hirschel Bernard;
No change in calculated creatinine clearance after tenofovir initiation among Thai patients.
The Journal of antimicrobial chemotherapy 2007;59(5):1034-7.
-
2007: Glass Tracy R; Weber Rainer; Vernazza Pietro L; Rickenbach Martin; Furrer Hansjakob; Bernasconi Enos; Cavassini Matthias; Hirschel Bernard; Battegay Manuel; Bucher Heiner C;
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
HIV clinical trials 2007;8(2):77-85.
-
2007: Hirschel Bernard
Review on structured treatment interruptions (STIs).
Topics in HIV medicine : a publication of the International AIDS Society, USA 2007;15(1):17; author reply 17.
-
2007: Ananworanich Jintanat; Hirschel Bernard
Intermittent therapy for the treatment of chronic HIV infection.
AIDS (London, England) 2007;21(2):123-34.
-
2007: Calmy Alexandra; Ford Nathan; Hirschel Bernard; Reynolds Steven J; Lynen Lut; Goemaere Eric; Garcia de la Vega Felipe; Perrin Luc; Rodriguez William
HIV viral load monitoring in resource-limited regions: optional or necessary?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):128-34.
-
2007: Elzi Luigia; Schlegel Matthias; Weber Rainer; Hirschel Bernard; Cavassini Matthias; Schmid Patrick; Bernasconi Enos; Rickenbach Martin; Furrer Hansjakob;
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):94-102.
-
2007: Fux Christoph A; Simcock Mathew; Wolbers Marcel; Bucher Heiner C; Hirschel Bernard; Opravil Milos; Vernazza Pietro; Cavassini Matthias; Bernasconi Enos; Elzi Luigia; Furrer Hansjakob;
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
Antiviral therapy 2007;12(8):1165-73.
-
2007: Keiser Olivia; Fellay Jacques; Opravil Milos; Hirsch Hans H; Hirschel Bernard; Bernasconi Enos; Vernazza Pietro L; Rickenbach Martin; Telenti Amalio; Furrer Hansjakob;
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.
Antiviral therapy 2007;12(8):1157-64.
-
2007: Simcock Mathew; Blasko Monika; Karrer Urs; Bertisch Barbara; Pless Miklos; Blumer Liisa; Vora Samir; Robinson James Owen; Bernasconi Enos; Terziroli Benedetta; Moirandat-Rytz Sophie; Furrer Hansjakob; Hirschel Bernard; Vernazza Pietro; Sendi Pedram; Rickenbach Martin; Bucher Heiner C; Battegay Manuel; Koller Michael T;
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Antiviral therapy 2007;12(6):931-9.
-
2007: Wolbers Marcel; Battegay Manuel; Hirschel Bernard; Furrer Hansjakob; Cavassini Matthias; Hasse Barbara; Vernazza Pietro L; Bernasconi Enos; Kaufmann Gilbert; Bucher Heiner C;
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Antiviral therapy 2007;12(6):889-97.
-
2007: Battegay Manuel; Fluckiger Ursula; Hirschel Bernard; Furrer Hansjakob
Late presentation of HIV-infected individuals.
Antiviral therapy 2007;12(6):841-51.
-
2007: Wunder Dorothea M; Bersinger Nick A; Fux Christoph A; Mueller Nicolas J; Hirschel Bernard; Cavassini Matthias; Elzi Luigia; Schmid Patrick; Bernasconi Enos; Mueller Bruno; Furrer Hansjakob;
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.
Antiviral therapy 2007;12(2):261-5.
-
2006: Glass T R; Ungsedhapand C; Wolbers M; Weber R; Vernazza P L; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher H C;
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
HIV medicine 2006;7(6):404-10.
-
2006: Ananworanich Jintanat; Gayet-Ageron Angèle; Le Braz Michelle; Prasithsirikul Wisit; Chetchotisakd Ploenchan; Kiertiburanakul Sasisopin; Munsakul Warangkana; Raksakulkarn Phitsanu; Tansuphasawasdikul Somboon; Sirivichayakul Sunee; Cavassini Matthias; Karrer Urs; Genné Daniel; Nüesch Reto; Vernazza Pietro; Bernasconi Enos; Leduc Dominic; Satchell Claudette; Yerly Sabine; Perrin Luc; Hill Andrew; Perneger Thomas; Phanuphak Praphan; Furrer Hansjakob; Cooper David; Ruxrungtham Kiat; Hirschel Bernard;
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial.
Lancet 2006;368(9534):459-65.
-
2006: Battegay Manuel; Nüesch Reto; Hirschel Bernard; Kaufmann Gilbert R
Immunological recovery and antiretroviral therapy in HIV-1 infection.
The Lancet infectious diseases 2006;6(5):280-7.
-
2006: Müller Nicolas J; Furrer Hansjakob; Kaiser Laurent; Hirschel Bernard; Cavassini Matthias; Fellay Jacques; Chave Jean-Philippe; Wüthrich Rudolf P; Weber Markus; Müllhaupt Beat; Candinas Daniel; Reichen Jürg; Giostra Emiliano; Mentha Gilles; Halkic Nermin; Hirsch Hans H; Weber Rainer;
HIV and solid organ transplantation: the Swiss experience.
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2006;136(11-12):194-6.
-
2006: Glass Tracy R; De Geest Sabina; Weber Rainer; Vernazza Pietro L; Rickenbach Martin; Furrer Hansjakob; Bernasconi Enos; Cavassini Matthias; Hirschel Bernard; Battegay Manuel; Bucher Heiner C
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2006;41(3):385-92.
-
2006: Ananworanich Jintanat; Hirschel Bernard; Sirivichayakul Sunee; Ubolyam Sasiwimol; Jupimai Thidarat; Prasithsirikul Wisit; Chetchotisakd Ploenchan; Kiertiburanakul Sasisopin; Munsakul Warangkana; Raksakulkarn Phitsanu; Tansuphasawadikul Somboon; Schutz Malte; Snowden Wendy; Ruxrungtham Kiat;
Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir.
Antiviral therapy 2006;11(5):631-5.
-
2006: Zinkernagel Annelies S; von Wyl Viktor; Ledergerber Bruno; Rickenbach Martin; Furrer Hansjakob; Battegay Manuel; Hirschel Bernard; Tarr Philip E; Opravil Milos; Bernasconi Enos; Schmid Patrick; Weber Rainer;
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study.
Antiviral therapy 2006;11(2):131-42.
-
2006: Abraham Shahnaz; Toutous-Trellu Laurence; Pechère Marc; Hugonnet Stéphane; Liassine Nadia; Yerly Sabine; Rohner Peter; Ninet Béatrice; Hirschel Bernard; Piguet Vincent
Increased incidence of sexually transmitted infections in Geneva, Switzerland.
Dermatology (Basel, Switzerland) 2006;212(1):41-6.
-
2005: Karrer Urs; Ledergerber Bruno; Furrer Hansjakob; Elzi Luigia; Battegay Manuel; Cavassini Matthias; Gayet-Ageron Angèle; Hirschel Bernard; Schmid Patrick; Russotti Marina; Weber Rainer; Speck Roberto F;
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.
AIDS (London, England) 2005;19(17):1987-94.
-
2005: Schüpbach Jörg; Günthard Huldrych; Joos Beda; Fischer Marek; Böni Jürg; Tomasik Zuzana; Yerly Sabine; Perrin Luc; Battegay Manuel; Furrer Hansjakob; Vernazza Pietro; Bernasconi Enos; Hirschel Bernard;
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):250-6.
-
2005: Toutous-Trellu Laurence; Abraham Shahnaz; Pechère Marc; Chavaz Pierre; Lübbe Jan; Schiffer Véronique; Hirschel Bernard; Saurat Jean-Hilaire; Piguet Vincent
Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection.
Archives of dermatology 2005;141(10):1203-8.
-
2005: Ananworanich Jintanat; Siangphoe Umaporn; Hill Andrew; Cardiello Peter; Apateerapong Wichitra; Hirschel Bernard; Mahanontharit Apicha; Ubolyam Sasiwimol; Cooper David; Phanuphak Praphan; Ruxrungtham Kiat
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
Journal of acquired immune deficiency syndromes (1999) 2005;39(5):523-9.
-
2005: Rauch Andri; Rickenbach Martin; Weber Rainer; Hirschel Bernard; Tarr Philip E; Bucher Heiner C; Vernazza Pietro; Bernasconi Enos; Zinkernagel Annelies S; Evison John; Furrer Hansjakob;
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(3):395-402.
-
2005: Kaufmann Gilbert R; Furrer Hansjakob; Ledergerber Bruno; Perrin Luc; Opravil Milos; Vernazza Pietro; Cavassini Matthias; Bernasconi Enos; Rickenbach Martin; Hirschel Bernard; Battegay Manuel;
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(3):361-72.
-
2005: Hirschel Bernard
Effect of rimonabant on weight reduction and cardiovascular risk.
Lancet 2005;366(9483):369; author reply 369-70.
-
2005: Joos Beda; Trkola Alexandra; Fischer Marek; Kuster Herbert; Rusert Peter; Leemann Christine; Böni Jürg; Oxenius Annette; Price David A; Phillips Rodney E; Wong Joseph K; Hirschel Bernard; Weber Rainer; Günthard Huldrych F;
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
Journal of virology 2005;79(14):9026-37.
-
2005: Matulionyte R; Garbino J; Uçkay I; Lambert J F; Hirschel B
Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(5):361-3.
-
2005: Tarr Philip E; Taffé Patrick; Bleiber Gabriela; Furrer Hansjakob; Rotger Margalida; Martinez Raquel; Hirschel Bernard; Battegay Manuel; Weber Rainer; Vernazza Pietro; Bernasconi Enos; Darioli Roger; Rickenbach Martin; Ledergerber Bruno; Telenti Amalio;
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
The Journal of infectious diseases 2005;191(9):1419-26.
-
2005: Fagard Catherine; Bandelier Cédric Y; Ananworanich Jintanat; Le Braz Michelle; Günthard Huldrych; Perneger Thomas; García Felipe; Hirschel Bernard;
Biphasic decline of CD4 cell count during scheduled treatment interruptions.
AIDS (London, England) 2005;19(4):439-41.
-
2005: Ananworanich Jintanat; Hirschel Bernard
Interrupting highly active antiretroviral therapy in patients with HIV.
Expert review of anti-infective therapy 2005;3(1):51-60.
-
2005: Cardiello Peter G; Hassink Elly; Ananworanich Jintanat; Srasuebkul Preeyaporn; Samor Tarika; Mahanontharit Apicha; Ruxrungtham Kiat; Hirschel Bernard; Lange Joep; Phanuphak Praphan; Cooper David A
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(4):594-600.
-
2005: Ananworanich Jintanat; Hill Andrew; Siangphoe Umaporn; Ruxrungtham Kiat; Prasithsirikul Wisit; Chetchotisakd Ploenchan; Kiertiburanakul Sasisopin; Munsakul Warangkana; Raksakulkarn Phitsanu; Tansuphasawadikul Somboon; Nuesch Reto; Cooper David A; Hirschel Bernard;
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients.
Antiviral therapy 2005;10(6):761-7.
-
2005: Young Jim; Weber Rainer; Rickenbach Martin; Furrer Hansjakob; Bernasconi Enos; Hirschel Bernard; Tarr Philip E; Vernazza Pietro; Battegay Manuel; Bucher Heiner C
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
Antiviral therapy 2005;10(5):585-91.
-
2005: Young Jim; Rickenbach Martin; Weber Rainer; Furrer Hansjakob; Bernasconi Enos; Hirschel Bernard; Tarr Philip E; Vernazza Pietro; Battegay Manuel; Bucher Heiner C
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
Antiviral therapy 2005;10(1):73-81.
-
2004: Ananworanich Jintanat; Siangphoe Umaporn; Mahanontharit Apicha; Hill Andrew; Hirschel Bernard; Ruxrungtham Kiat
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
Antiviral therapy 2004;9(6):1035-6.
-
2004: Vanhems Philippe; Voirin Nicolas; Philippe Pierre; Hirschel Bernard; Brassard Joelle; Carr Andrew; Cooper David A; Perrin Luc; Allard Robert;
The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysis.
Journal of acquired immune deficiency syndromes (1999) 2004;37(4):1529-33.
-
2004: Fischer Marek; Joos Beda; Hirschel Bernard; Bleiber Gabriela; Weber Rainer; Günthard Huldrych F;
Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
The Journal of infectious diseases 2004;190(11):1979-88.
-
2004: Battegay M; Hirschel B
[Primary HIV infection]
Therapeutische Umschau. Revue thérapeutique 2004;61(10):609-12.
-
2004: Autar R S; Ananworanich J; Apateerapong W; Sankote J; Hill A; Hirschel B; Cooper D; Lange J; Phanuphak P; Ruxrungtham K; Burger D
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.
The Journal of antimicrobial chemotherapy 2004;54(4):785-90.
-
2004: Hasse Barbara; Ledergerber Bruno; Egger Matthias; Flepp Markus; Bachmann Stefano; Bernasconi Enos; Egger Martin; Guyot Sophie; Hirschel Bernard; Weber Rainer; Günthard Huldrych F;
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study.
AIDS research and human retroviruses 2004;20(9):909-15.
-
2004: Yerly Sabine; Günthard Huldrych F; Fagard Catherine; Joos Béda; Perneger Thomas V; Hirschel Bernard; Perrin Luc;
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions.
AIDS (London, England) 2004;18(14):1951-3.
-
2004: Trkola Alexandra; Kuster Herbert; Leemann Christine; Oxenius Annette; Fagard Catherine; Furrer Hansjakob; Battegay Manuel; Vernazza Pietro; Bernasconi Enos; Weber Rainer; Hirschel Bernard; Bonhoeffer Sebastian; Günthard Huldrych F;
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
Blood 2004;104(6):1784-92.
-
2004: Scherer Almut; Frater John; Oxenius Annette; Agudelo Juliet; Price David A; Günthard Huldrych F; Barnardo Martin; Perrin Luc; Hirschel Bernard; Phillips Rodney E; McLean Angela R;
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(33):12266-70.
-
2004: Glass Tracy R; Young Jim; Vernazza Pietro L; Rickenbach Martin; Weber Rainer; Cavassini Matthias; Hirschel Bernard; Battegay Manuel; Bucher Heiner C;
Is unsafe sexual behaviour increasing among HIV-infected individuals?
AIDS (London, England) 2004;18(12):1707-14.
-
2004: Felley Christian; Morris Michael A; Wonkam Ambroise; Hirschel Bernard; Flepp Markus; Wolf Katja; Furrer Hansjakob; Battegay Manuel; Bernasconi Enos; Telenti Amalio; Frossard Jean-Louis
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study.
AIDS (London, England) 2004;18(11):1521-7.
-
2004: Plana Montserrat; Garcia Felipe; Oxenius Annette; Ortiz Gabriel M; Lopez Anna; Cruceta Anna; Mestre Gabriel; Fumero Emilio; Fagard Catherine; Sambeat Maria Antonia; Segura Ferran; Miró José M; Arnedo Mireia; Lopalcos Lucia; Pumarola Tomas; Hirschel Bernard; Phillips Rodney E; Nixon Douglas F; Gallart Teresa; Gatell Jose M
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):791-9.
-
2004: Yerly Sabine; Jost Stéphanie; Telenti Amalio; Flepp Markus; Kaiser Laurent; Chave Jean-Philippe; Vernazza Pietro; Battegay Manuel; Furrer Hansjakob; Chanzy Bruno; Burgisser Philippe; Rickenbach Martin; Gebhardt Martin; Bernard Marie-Charlotte; Perneger Thomas; Hirschel Bernard; Perrin Luc;
Infrequent transmission of HIV-1 drug-resistant variants.
Antiviral therapy 2004;9(3):375-84.
-
2004: Karsegard Veronique L; Raguso Comasia A; Genton Laurence; Hirschel Bernard; Pichard Claude
L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functions.
Nutrition (Burbank, Los Angeles County, Calif.) 2004;20(6):515-20.
-
2004: Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat J-H; Pechère M
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients]
Annales de dermatologie et de vénéréologie 2004;131(5):445-9.
-
2004: Kaufmann Gilbert R; Khanna Nina; Weber Rainer; Perrin Luc; Furrer Hansjakob; Cavassini Matthias; Ledergerber Bruno; Vernazza Pietro; Bernasconi Enos; Rickenbach Martin; Hirschel Bernard; Battegay Manuel;
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
Antiviral therapy 2004;9(2):263-74.
-
2004: Kaiser Laurent; Hirschel Bernard
Antibiotics for acute rhinosinusitis.
Archives of internal medicine 2004;164(5):568; author reply 570.
-
2004: Fischer Marek; Joos Beda; Wong Joseph K; Ott Peter; Opravil Milos; Hirschel Bernhard; Weber Rainer; Günthard Huldrych F;
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy.
The Journal of infectious diseases 2004;189(2):273-85.
-
2004: Young Jim; De Geest Sabina; Spirig Rebecca; Flepp Markus; Rickenbach Martin; Furrer Hansjakob; Bernasconi Enos; Hirschel Bernard; Telenti Amalio; Vernazza Pietro; Battegay Manuel; Bucher Heiner C;
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
BMJ (Clinical research ed.) 2004;328(7430):15.
-
2003: Hirschel Bernard
Substitution for protease inhibitors in HIV therapy.
The New England journal of medicine 2003;349(25):2460-1; author reply 2460-1.
-
2003: Trkola Alexandra; Kuster Herbert; Leemann Christine; Ruprecht Claudia; Joos Beda; Telenti Amalio; Hirschel Bernhard; Weber Rainer; Bonhoeffer Sebastian; Günthard Huldrych F;
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.
Journal of virology 2003;77(24):13146-55.
-
2003: Metzner Karin J; Bonhoeffer Sebastian; Fischer Marek; Karanicolas Rose; Allers Kristina; Joos Beda; Weber Rainer; Hirschel Bernard; Kostrikis Leondios G; Günthard Huldrych F;
Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions.
The Journal of infectious diseases 2003;188(10):1433-43.
-
2003: Yerly Sabine; Fagard Catherine; Günthard Huldrych F; Hirschel Bernard; Perrin Luc;
Drug resistance mutations during structured treatment interruptions.
Antiviral therapy 2003;8(5):411-5.
-
2003: Kaufmann Gilbert R; Perrin Luc; Pantaleo Guiseppe; Opravil Milos; Furrer Hansjakob; Telenti Amalio; Hirschel Bernard; Ledergerber Bruno; Vernazza Pietro; Bernasconi Enos; Rickenbach Martin; Egger Matthias; Battegay Manuel;
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Archives of internal medicine 2003;163(18):2187-95.
-
2003: Hirsch Martin S; Steigbigel Roy T; Staszewski Scholomo; McMahon Deborah; Fischl Margaret A; Hirschel Bernard; Squires Kathleen; DiNubile Mark J; Harvey Charlotte M; Chen Joshua; Leavitt Randi Y;
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1119-24.
-
2003: Ananworanich Jintanat; Nuesch Reto; Le Braz Michelle; Chetchotisakd Ploechan; Vibhagool Asda; Wicharuk Saijai; Ruxrungtham Kiat; Furrer Hansjakob; Cooper David; Hirschel Bernard; Bernasconi E; Cavassini M; Ebnöther C; Fagard C; Genné D; Khanna N; Perrin L; Phanupak P; Ubolyam S; Vernazza P; Yerly S;
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial.
AIDS (London, England) 2003;17(15):F33-7.
-
2003: Staehelin Cornelia; Rickenbach Martin; Low Nicola; Egger Martin; Ledergerber Bruno; Hirschel Bernard; D'Acremont Valérie; Battegay Manuel; Wagels Thomas; Bernasconi Enos; Kopp Christine; Furrer Hansjakob;
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
AIDS (London, England) 2003;17(15):2237-44.
-
2003: Jaggy Christian; von Overbeck Jan; Ledergerber Bruno; Schwarz Claude; Egger Matthias; Rickenbach Martin; Furrer Hans-Jakob; Telenti Amalio; Battegay Manuel; Flepp Markus; Vernazza Pietro; Bernasconi Enos; Hirschel Bernard;
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.
Lancet 2003;362(9387):877-8.
-
2003: Hirschel Bernard
Beware of drug holidays before HIV salvage therapy.
The New England journal of medicine 2003;349(9):827-8.
-
2003: Wolf Katja; Young James; Rickenbach Martin; Vernazza Pietro; Flepp Markus; Furrer Hansjakob; Bernasconi Enos; Hirschel Bernard; Telenti Amalio; Weber Rainer; Bucher Heiner C;
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2003;33(4):494-9.
-
2003: Fagard Catherine; Le Braz Michelle; Günthard Huldrych; Hirsch Hans H; Egger Martin; Vernazza Pietro; Bernasconi Enos; Telenti Amalio; Ebnöther Corinna; Oxenius Annette; Perneger Thomas; Perrin Luc; Hirschel Bernard;
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.
AIDS (London, England) 2003;17(10):1487-92.
-
2003: Oxenius Annette; Hirschel Bernard
Structured treatment interruptions in HIV infection: benefit or disappointment?
Expert review of anti-infective therapy 2003;1(1):129-39.
-
2003: Fagard Catherine; Oxenius Annette; Günthard Huldrych; Garcia Felipe; Le Braz Michelle; Mestre Gabriel; Battegay Manuel; Furrer Hansjakob; Vernazza Pietro; Bernasconi Enos; Telenti Amalio; Weber Rainer; Leduc Dominique; Yerly Sabine; Price David; Dawson Sara J; Klimkait Thomas; Perneger Thomas V; McLean Angela; Clotet Bonaventura; Gatell Jose M; Perrin Luc; Plana Montserrat; Phillips Rodney; Hirschel Bernard;
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Archives of internal medicine 2003;163(10):1220-6.
-
2003: Fischer Marek; Trkola Alexandra; Joos Beda; Hafner Roland; Joller Helen; Muesing Mark A; Kaufman David R; Berli Esther; Hirschel Bernard; Weber Rainer; Günthard Huldrych F;
Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo.
Antiviral therapy 2003;8(2):97-104.
-
2003: Hirschel Bernard
Questions about the antimalarial amodiaquine.
Lancet 2003;361(9364):1229; author reply 1229-30.
-
2003: Vanhems Philippe; Voirin Nicolas; Hirschel Bernard; Cooper David A; Vizzard Jeanette; Carr Andrew; Perrin Luc;
Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS.
Journal of acquired immune deficiency syndromes (1999) 2003;32(5):542-4.
-
2003: de Lucia Sylvain; Hirschel Bernard
[Prophylaxis after HIV exposure]
Revue médicale de la Suisse romande 2003;123(3):159-64.
-
2003: Garbino J; Lew D; Hirschel B; Rohner P
Caspofungin in the treatment of oropharyngeal candidiasis.
International journal of clinical practice 2003;57(2):143-4.
-
2003: Calmy Alexandra; Hirschel Bernard; Hans Didier; Karsegard Véronique L; Meier Christoph A
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy.
AIDS (London, England) 2003;17(5):770-2.
-
2003: Hirschel Bernard
Antiretroviral treatment and research in resource-poor countries.
Lancet 2003;361(9355):434-5.
-
2003: Fischer Marek; Hafner Roland; Schneider Christine; Trkola Alexandra; Joos Beda; Joller Helen; Hirschel Bernard; Weber Rainer; Günthard Huldrych F;
HIV RNA in plasma rebounds within days during structured treatment interruptions.
AIDS (London, England) 2003;17(2):195-9.
-
2003: Hirschel Bernard
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et al.
AIDS (London, England) 2003;17 Suppl 4():S117-9.
-
2003: Hirschel Bernard
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et al.
AIDS (London, England) 2003;17 Suppl 4():S116-7.
-
2003: Hirschel Bernard
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et al.
AIDS (London, England) 2003;17 Suppl 4():S114-6.
-
2003: Hirschel Bernard
Is autovaccination dead?
Research initiative, treatment action : RITA 2003;9(2):16.
-
2002: Oxenius Annetie; Sewell Andrew K; Dawson Sara J; Günthard Huldrych F; Fischer Marek; Gillespie Geraldine M; Rowland-Jones Sarah L; Fagard Catherine; Hirschel Bernard; Phillips Rodney E; Price David A;
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.
Journal of clinical immunology 2002;22(6):363-74.
-
2002: Oxenius Annette; Price David A; Dawson Sara J; Günthard Huldrych F; Fischer Marek; Perrin Luc; Ramirez Elbe; Fagard Catherine; Hirschel Bernard; Scullard George; Weber Jonathan N; McLean Angela R; Phillips Rodney E;
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
AIDS (London, England) 2002;16(17):2317-22.
-
2002: Vanhems Philippe; Routy Jean-Pierre; Hirschel Bernard; Baratin Dominique; Vora Samir; Maenza Janine; Carr Andrew; Trépo Christian; Touraine Jean-Louis; Gillibert René-Pierre; Collier Ann C; Cooper David A; Vizzard Jeanette; Sékaly Rafick-Pierre; Fabry Jacques; Perrin Luc;
Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age.
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):318-21.
-
2002: Vanhems Philippe; Caillat-Vallet Emmanuelle; Hirschel Bernard; Routy Jean-Pierre; Carr Andrew; Vizzard Jeanette; Cooper David A; Perrin Luc;
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual.
AIDS (London, England) 2002;16(16):2234-6.
-
2002: Bucher H C; Bichsel M; Taffé P; Furrer H; Telenti A; Hirschel B; Weber R; Bernasconi E; Vernazza P; Minder C; Battegay M;
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study.
HIV medicine 2002;3(4):247-53.
-
2002: Oxenius Annette; Price David A; Günthard Huldrych F; Dawson Sara J; Fagard Catherine; Perrin Luc; Fischer Marek; Weber Rainer; Plana Montserrat; García Felipe; Hirschel Bernard; McLean Angela; Phillips Rodney E
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(21):13747-52.
-
2002: Oxenius Annette; McLean Angela R; Fischer Marek; Price David A; Dawson Sarah J; Hafner Roland; Schneider Christine; Joller Helen; Hirschel Bernard; Phillips Rodney E; Weber Rainer; Günthard Huldrych F;
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
Journal of virology 2002;76(20):10169-76.
-
2002: Bernasconi Enos; Boubaker Karim; Junghans Cornelia; Flepp Markus; Furrer Hans-Jakob; Haensel Alexander; Hirschel Bernard; Boggian Katia; Chave Jean-Philippe; Opravil Milos; Weber Rainer; Rickenbach Martin; Telenti Amalio;
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):50-5.
-
2002: Greub Gilbert; Cozzi-Lepri Alessandro; Ledergerber Bruno; Staszewski Schlomo; Perrin Luc; Miller Veronica; Francioli Patrick; Furrer Hansjakob; Battegay Manuel; Vernazza Pietro; Bernasconi Enos; Günthard Huldrych F; Hirschel Bernard; Phillips Andrew N; Telenti Amalio;
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.
AIDS (London, England) 2002;16(14):1967-9.
-
2002: Jost Stephanie; Bernard Marie-Charlotte; Kaiser Laurent; Yerly Sabine; Hirschel Bernard; Samri Assia; Autran Brigitte; Goh Li-Ean; Perrin Luc
A patient with HIV-1 superinfection.
The New England journal of medicine 2002;347(10):731-6.
-
2002: Opravil Milos; Ledergerber Bruno; Furrer Hansjakob; Hirschel Bernard; Imhof Alexander; Gallant Serge; Wagels Thomas; Bernasconi Enos; Meienberg Fabian; Rickenbach Martin; Weber Rainer;
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.
AIDS (London, England) 2002;16(10):1371-81.
-
2002: Cominelli Silvano; Raguso Comasia A; Karsegard Laurie; Hirschel Bernard; Gaillard Rolf; Genton Laurence; Pichard Claude
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study.
Nutrition (Burbank, Los Angeles County, Calif.) 2002;18(7-8):583-6.
-
2002: Hirschel Bernard; Garbino Jorge
New drugs, old drugs - dear drugs, cheap drugs.
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2002;132(23-24):301-2.
-
2002: Fischer Marek; Wong Joseph K; Russenberger Doris; Joos Beda; Opravil Milos; Hirschel Bernhard; Trkola Alexandra; Kuster Herbert; Weber Rainer; Günthard Huldrych F;
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.
Antiviral therapy 2002;7(2):91-103.
-
2002: Opravil Milos; Hirschel Bernard; Lazzarin Adriano; Furrer Hansjakob; Chave Jean-Philippe; Yerly Sabine; Bisset Leslie R; Fischer Marek; Vernazza Pietro; Bernasconi Enos; Battegay Manuel; Ledergerber Bruno; Günthard Huldrych; Howe Colin; Weber Rainer; Perrin Luc;
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
The Journal of infectious diseases 2002;185(9):1251-60.
-
2002: Mocroft A; Phillips A N; Friis-Møller N; Colebunders R; Johnson A M; Hirschel B; Saint-Marc T; Staub T; Clotet B; Lundgren J D;
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.
Antiviral therapy 2002;7(1):21-30.
-
2002: Taffé Patrick; Rickenbach Martin; Hirschel Bernard; Opravil Milos; Furrer Hansjakob; Janin Pascal; Bugnon Florence; Ledergerber Bruno; Wagels Thomas; Sudre Philippe;
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study.
AIDS (London, England) 2002;16(5):747-55.
-
2002: Hirschel Bernard; Flepp Markus; Bucher Heiner C; Zellweger Claudine; Telenti Amalio; Wagels Thomas; Bernasconi Enos; Ledergerber Bruno;
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort.
AIDS (London, England) 2002;16(3):381-5.
-
2002: Deeks Steven G; Hirschel Bernard
Supervised interruptions of antiretroviral therapy.
AIDS (London, England) 2002;16 Suppl 4():S157-69.
-
2001: Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave J P; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1931-7.
-
2001: Yerly S; Vora S; Rizzardi P; Chave J P; Vernazza P L; Flepp M; Telenti A; Battegay M; Veuthey A L; Bru J P; Rickenbach M; Hirschel B; Perrin L;
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.
AIDS (London, England) 2001;15(17):2287-92.
-
2001: Fellay J; Boubaker K; Ledergerber B; Bernasconi E; Furrer H; Battegay M; Hirschel B; Vernazza P; Francioli P; Greub G; Flepp M; Telenti A;
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.
Lancet 2001;358(9290):1322-7.
-
2001: Friedl A C; Ledergerber B; Flepp M; Hirschel B; Telenti A; Furrer H; Bucher H C; Bernasconi E; Weber R;
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study.
AIDS (London, England) 2001;15(14):1793-800.
-
2001: Hirschel B
Planned interruptions of anti-HIV treatment.
The Lancet infectious diseases 2001;1(1):53-9.
-
2001: Kaiser L; Morabia A; Stalder H; Ricchetti A; Auckenthaler R; Terrier F; Hirschel B; Khaw N; Lacroix J S; Lew D
Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(7):445-51.
-
2001: Flepp M; Schiffer V; Weber R; Hirschel B
Modern anti-HIV therapy.
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001;131(15-16):207-13.
-
2001: Oxenius A; Günthard H F; Hirschel B; Fidler S; Weber J N; Easterbrook P J; Bell J I; Phillips R E; Price D A
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.
European journal of immunology 2001;31(4):1115-21.
-
2001: Battegay M; Vernazza P L; Bernasconi E; Flepp M; Sendi P; Erb P; Malinverni R; Jaccard C; Morgenthaler S; Bedoucha V; Hirschel B;
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients.
HIV medicine 2001;2(1):35-42.
-
2000: Yerly S; Perneger T V; Vora S; Hirschel B; Perrin L
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.
AIDS (London, England) 2000;14(18):2805-12.
-
2000: Greub G; Ledergerber B; Battegay M; Grob P; Perrin L; Furrer H; Burgisser P; Erb P; Boggian K; Piffaretti J C; Hirschel B; Janin P; Francioli P; Flepp M; Telenti A
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Lancet 2000;356(9244):1800-5.
-
2000: Friedli A; Krischer J; Hirschel B; Saurat J H; Pechère M
An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDS.
Journal of the American Academy of Dermatology 2000;43(5 Pt 2):913-5.
-
2000: Rutschmann O T; Vernazza P L; Bucher H C; Opravil M; Ledergerber B; Telenti A; Malinverni R; Bernasconi E; Fagard C; Leduc D; Perrin L; Hirschel B
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(14):2145-51.
-
2000: Vanhems P; Hirschel B; Phillips A N; Cooper D A; Vizzard J; Brassard J; Perrin L
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS.
The Journal of infectious diseases 2000;182(1):334-7.
-
2000: Vanhems P; Gaudet R; Hirschel B; Imrie A; Conway B; Rouleau D; Vizzard J; Perrin L; Cooper D A; Yerly S
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
AIDS (London, England) 2000;14(8):1065-7.
-
2000: Khanna N; Klimkait T; Schiffer V; Irigoyen J; Telenti A; Hirschel B; Battegay M
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(7):791-9.
-
2000: Vanhems P; Hughes J; Collier A C; Vizzard J; Perrin L; Cooper D A; Hirschel B; Corey L
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney.
AIDS (London, England) 2000;14(4):375-81.
-
2000: Yerly S; Kaiser L; Perneger T V; Cone R W; Opravil M; Chave J P; Furrer H; Hirschel B; Perrin L
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(3):243-9.
-
2000: Ricchetti A; Lacroix J S; Kaiser L; Morabia A; Stalder H; Auckenthaler R; Terrier F; Hirschel B; Khaw N; Lew D
[Symptoms and clinical and radiological signs predicting the bacterial origin of acute rhinosinusitis]
Schweizerische medizinische Wochenschrift 2000;Suppl 125():27S-29S.
-
1999: Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
JAMA : the journal of the American Medical Association 1999;282(23):2220-6.
-
1999: Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
The Journal of infectious diseases 1999;180(6):1803-8.
-
1999: Ninet B; Rutschmann O; Burkhardt K; Metral C; Borisch B; Hirschel B
Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort Study.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1999;8(3):145-51.
-
1999: Yerly S; Rutschmann O T; Opravil M; Marchal F; Hirschel B; Perrin L
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study.
The Journal of infectious diseases 1999;180(3):850-3.
-
1999: Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
The Journal of infectious diseases 1999;180(3):659-65.
-
1999: Zinkernagel C; Ledergerber B; Battegay M; Cone R W; Vernazza P; Hirschel B; Opravil M
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.
AIDS (London, England) 1999;13(12):1587-9.
-
1999: Opravil M; Hirschel B; Bucher H C; Lüthy R
A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
International journal of STD & AIDS 1999;10(6):369-75.
-
1999: Vanhems P; Dassa C; Lambert J; Cooper D A; Perrin L; Vizzard J; Hirschel B; Kinloch-de Loës S; Carr A; Allard R
Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 1999;21(2):99-106.
-
1999: Realini L; De Ridder K; Hirschel B; Portaels F
Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense.
Diagnostic microbiology and infectious disease 1999;34(1):45-50.
-
1999: Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza P L; Rickenbach M; Flepp M; Malinverni R
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
The New England journal of medicine 1999;340(17):1301-6.
-
1999: Ledergerber B; Egger M; Opravil M; Telenti A; Hirschel B; Battegay M; Vernazza P; Sudre P; Flepp M; Furrer H; Francioli P; Weber R
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.
Lancet 1999;353(9156):863-8.
-
1999: Lorenzi P; Opravil M; Hirschel B; Chave J P; Furrer H J; Sax H; Perneger T V; Perrin L; Kaiser L; Yerly S
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.
AIDS (London, England) 1999;13(2):F17-21.
-
1999: Sudre P; San Millán Ruiz D; Fagard C; Perrin L; Hirschel B J
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure]
Schweizerische medizinische Wochenschrift 1999;129(8):314-8.
-
1999: Hirschel B; Opravil M
The year in review: antiretroviral treatment.
AIDS (London, England) 1999;13 Suppl A():S177-87.
-
1998: Lorenzi P; Spicher V M; Laubereau B; Hirschel B; Kind C; Rudin C; Irion O; Kaiser L
Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.
AIDS (London, England) 1998;12(18):F241-7.
-
1998: Broers B; Junet C; Bourquin M; Déglon J J; Perrin L; Hirschel B
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
AIDS (London, England) 1998;12(15):2059-66.
-
1998: Realini L; De Ridder K; Palomino J; Hirschel B; Portaels F
Microaerophilic conditions promote growth of Mycobacterium genavense.
Journal of clinical microbiology 1998;36(9):2565-70.
-
1998: Kaiser L; Lew D; Hirschel B; Auckenthaler R; Morabia A; Bénédict P; Terrier F; Stalder H
Radiological maxillary sinusitis in patients with common cold.
The Journal of family practice 1998;47(1):72-4.
-
1998: Perrin L; Yerly S; Marchal F; Schockmel G A; Hirschel B; Fox C H; Pantaleo G
Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.
The Journal of infectious diseases 1998;177(6):1497-501.
-
1998: Rutschmann O T; Opravil M; Iten A; Malinverni R; Vernazza P L; Bucher H C; Bernasconi E; Sudre P; Leduc D; Yerly S; Perrin L H; Hirschel B
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.
AIDS (London, England) 1998;12(8):F71-7.
-
1998: Yerly S; Rakik A; De Loes S K; Hirschel B; Descamps D; Brun-Vézinet F; Perrin L
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.
Journal of virology 1998;72(5):3520-3.
-
1998: Krischer J; Rutschmann O; Hirschel B; Vollenweider-Roten S; Saurat J H; Pechère M
Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study.
Journal of the American Academy of Dermatology 1998;38(4):594-8.
-
1998: Sachsenberg N; Perelson A S; Yerly S; Schockmel G A; Leduc D; Hirschel B; Perrin L
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
The Journal of experimental medicine 1998;187(8):1295-303.
-
1998: Vanhems P; Lambert J; Cooper D A; Perrin L; Carr A; Hirschel B; Vizzard J; Kinloch-de Loës S; Allard R
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(2):323-9.
-
1998: Yerly S; Perneger T V; Hirschel B; Dubuis O; Matter L; Malinverni R; Furrer H; Perrin L
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.
Archives of internal medicine 1998;158(3):247-52.
-
1998: Pichard C; Sudre P; Karsegard V; Yerly S; Slosman D O; Delley V; Perrin L; Hirschel B
A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study.
AIDS (London, England) 1998;12(1):53-63.
-
1998: Rutschmann O T; Opravil M; Iten A; Malinverni R; Vernazza P L; Bucher H; Bernasconi E; Perrin L H; Yerly S; Hirschel B
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
Antiviral therapy 1998;3 Suppl 4():65-7.
-
1997: Burquier V; Koralnik I J; Vibert D; Burkhard P; Beaumanoir A; Jallon P; Mayer E; Hirschel B
[Effect of antiretroviral treatment on early electroencephalographic and otoneurologic manifestations in HIV infection and prognostic importance of verified perturbations]
Neurophysiologie clinique = Clinical neurophysiology 1997;27(6):508-19.
-
1997: Morawetz R A; Rizzardi G P; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser M P; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
European journal of immunology 1997;27(12):3223-7.
-
1997: Egger M; Hirschel B; Francioli P; Sudre P; Wirz M; Flepp M; Rickenbach M; Malinverni R; Vernazza P; Battegay M
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.
BMJ (Clinical research ed.) 1997;315(7117):1194-9.
-
1997: Realini L; Van Der Stuyft P; De Ridder K; Hirschel B; Portaels F
Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures.
Journal of clinical microbiology 1997;35(11):2791-4.
-
1997: Lorenzi P; Yerly S; Abderrakim K; Fathi M; Rutschmann O T; von Overbeck J; Leduc D; Perrin L; Hirschel B
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.
AIDS (London, England) 1997;11(12):F95-9.
-
1997: Rutschmann O T; Pechère M; Krischer J; Perrin L; Hirschel B
Chemotherapy for AIDS-related malignancies does not increase HIV viraemia.
AIDS (London, England) 1997;11(7):944-5.
-
1997: Vanhems P; Allard R; Cooper D A; Perrin L; Vizzard J; Hirschel B; Kinloch-de Löes S; Carr A; Lambert J
Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):965-70.
-
1997: Stalder N; Sudre P; Olmari M; Opravil M; Gabriel V; Sansonetti A; von Overbeck J; Herbort C P; Hirschel B
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(4):620-4.
-
1997: Opravil M; Pechère M; Speich R; Joller-Jemelka H I; Jenni R; Russi E W; Hirschel B; Lüthy R
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
American journal of respiratory and critical care medicine 1997;155(3):990-5.
-
1997: Rutschmann O; Hirschel B
Antiretroviral therapy: a guide to the most important trials.
Schweizerische medizinische Wochenschrift 1997;127(11):436-43.
-
1997: Perrin L; Yerly S; Charvier A; Figueras G; Schockmel G A; Hirschel B
Zidovudine plus didanosine in primary HIV-1 infection.
Antiviral therapy 1997;2(1):5-11.
-
1996: Yerly S; Rakik A; Kinloch-de-Loes S; Erb P; Vernazza P; Hirschel B; Perrin L
[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]
Schweizerische medizinische Wochenschrift 1996;126(43):1845-8.
-
1996: Ninet B; Monod M; Emler S; Pawlowski J; Metral C; Rohner P; Auckenthaler R; Hirschel B
Two different 16S rRNA genes in a mycobacterial strain.
Journal of clinical microbiology 1996;34(10):2531-6.
-
1996: Kinloch-de-Loës S; Perrin L H; Hirschel B J; Perneger T V
Controversies: does the CD4+ cell count reflect clinical efficacy?
JAMA : the journal of the American Medical Association 1996;276(15):1219; author reply 1919-20.
-
1996: Perrin L; Rakik A; Yerly S; Baumberger C; Kinloch-de Loës S; Pechère M; Hirschel B
Combined therapy with zidovudine and L-697,661 in primary HIV infection.
AIDS (London, England) 1996;10(11):1233-7.
-
1996: Yerly S; Denereaz N; Mermillod B; Hirschel B; Perrin L
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients.
Antiviral therapy 1996;1(3):167-71.
-
1996: Pechère M; Krischer J; Rosay A; Hirschel B; Saurat J H
Red fingers syndrome in patients with HIV and hepatitis C infection.
Lancet 1996;348(9021):196-7.
-
1996: Emler S; Praplan P; Rohner P; Auckenthaler R; Hirschel B
[Disseminated infection with Mycobacterium celatum]
Schweizerische medizinische Wochenschrift 1996;126(24):1062-5.
-
1996: Kaiser L; Lew D; Hirschel B; Auckenthaler R; Morabia A; Heald A; Benedict P; Terrier F; Wunderli W; Matter L; Germann D; Voegeli J; Stalder H
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions.
Lancet 1996;347(9014):1507-10.
-
1996: Galetto-Lacour A; Yerly S; Perneger T V; Baumberger C; Hirschel B; Perrin L
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.
The Journal of infectious diseases 1996;173(6):1388-93.
-
1996: Van Delden C; Gabriel V; Sudre P; Flepp M; von Overbeck J; Hirschel B
Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort Study.
AIDS (London, England) 1996;10(5):509-13.
-
1996: Wunderli W; Miner R; Wintsch J; von Gunten S; Hirsch H H; Hirschel B
Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(5):864-5.
-
1996: Liberek V; Soravia C; Ninet B; Hirschel B; Siegrist C A
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child.
The Pediatric infectious disease journal 1996;15(3):269-70.
-
1996: Portaels F; Realini L; Bauwens L; Hirschel B; Meyers W M; de Meurichy W
Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey.
Journal of clinical microbiology 1996;34(2):319-23.
-
1995: Bosquée L; Böttger E C; De Beenhouwer H; Fonteyne P A; Hirschel B; Larsson L; Meyers W M; Palomino J C; Realini L; Rigouts L
Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods.
Journal of clinical microbiology 1995;33(10):2670-4.
-
1995: Renold C; wintsch J; Filthuth I; Wunderli W; Lew D; Hirschel B
Pneumonia and respiratory distress syndrome during primary infection with Toxoplasma gondii.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):690-1.
-
1995: von Overbeck J; Perey L; Iten A; Pechère M; Ruffieux P; Hirschel B
Human chronic gonadotropin for AIDS-related Kaposi's sarcoma.
Lancet 1995;346(8975):642-3.
-
1995: Kinloch-De Loës S; Hirschel B J; Hoen B; Cooper D A; Tindall B; Carr A; Saurat J H; Clumeck N; Lazzarin A; Mathiesen L
A controlled trial of zidovudine in primary human immunodeficiency virus infection.
The New England journal of medicine 1995;333(7):408-13.
-
1995: Kaiser L; Perrin L; Hirschel B; Furrer H; Von Overbeck J; Olmari M; Yerly S
Foscarnet decreases human immunodeficiency virus RNA.
The Journal of infectious diseases 1995;172(1):225-7.
-
1995: Emler S; Ninet B; Rohner P; Auckenthaler R; Jäger D; Hirschel B
Molecular basis for cross-reactivity between a strain of Mycobacterium terrae and DNA probes for Mycobacterium tuberculosis complex.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(7):627-9.
-
1995: Yerly S; Kaiser L; Baumberger C; Hirschel B; Perrin L H
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(4):358-64.
-
1995: Emler S; Böttger E C; Broers B; Cassis I; Perrin L; Hirschel B
Growth-deficient mycobacteria in patients with AIDS: diagnosis by analysis of DNA amplified from blood or tissue.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(4):772-5.
-
1995: Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):531-41.
-
1995: Yerly S; Kaiser L; Mermillod B; Baumberger C; Hirschel B; Perrin L
Response of HIV RNA to didanosine as a predictive marker of survival.
AIDS (London, England) 1995;9(2):159-63.
-
1995: Galetto-Lacour A; Kinloch-de Loës S; Hirschel B; Perrin L
[Primary HIV infection: an often suspected diagnosis but confirmed late]
Schweizerische medizinische Wochenschrift 1995;125(8):341-6.
-
1994: Emler S; Rochat T; Rohner P; Perrot C; Auckenthaler R; Perrin L; Hirschel B
Chronic destructive lung disease associated with a novel mycobacterium.
American journal of respiratory and critical care medicine 1994;150(1):261-5.
-
1994: Broers B; Morabia A; Hirschel B
A cohort study of drug users' compliance with zidovudine treatment.
Archives of internal medicine 1994;154(10):1121-7.
-
1994: Chevalley G F; Olmari M; Bonvin E R; Dosso A A; Sansonetti A; Hirschel B; Leuenberger P M
[Diagnostic aspects and frequency of retrocorneal precipitates in diagnosis of cytomegalovirus retinitis in the HIV+ patient]
Klinische Monatsblätter für Augenheilkunde 1994;204(5):348-9.
-
1993: Baumberger C; Kinloch-de-Loës S; Yerly S; Hirschel B; Perrin L
High levels of circulating RNA in patients with symptomatic HIV-1 infection.
AIDS (London, England) 1993;7 Suppl 2():S59-64.
-
1993: Kinloch-de Loës S; de Saussure P; Saurat J H; Stalder H; Hirschel B; Perrin L H
Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(1):59-65.
-
1992: Yerly S; Chamot E; Hirschel B; Perrin L H
Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.
The Journal of infectious diseases 1992;166(2):269-76.
-
1992: Renold C; Sugar A; Chave J P; Perrin L; Delavelle J; Pizzolato G; Burkhard P; Gabriel V; Hirschel B
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Medicine 1992;71(4):224-39.
-
1992: Chamot E; de Saussure P; Hirschel B; Déglon J J; Perrin L H
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.
AIDS (London, England) 1992;6(4):430-1.
-
1992: Pugin J; Vanhems P; Hirschel B; Chave J P; Flepp M
Extreme elevations of serum lactic dehydrogenase differentiating pulmonary toxoplasmosis from Pneumocystis pneumonia.
The New England journal of medicine 1992;326(18):1226.
-
1991: Yerly S; Chamot E; Déglon J J; Hirschel B; Perrin L H
Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.
The Journal of infectious diseases 1991;164(5):965-8.
-
1991: Heald A; Flepp M; Chave J P; Malinverni R; Rüttimann S; Gabriel V; Renold C; Sugar A; Hirschel B
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
Annals of internal medicine 1991;115(10):760-3.
-
1991: Hirschel B; Lazzarin A; Chopard P; Opravil M; Furrer H J; Rüttimann S; Vernazza P; Chave J P; Ancarani F; Gabriel V
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
The New England journal of medicine 1991;324(16):1079-83.
-
1991: Hausler R; Vibert D; Koralnik I J; Hirschel B
Neuro-otological manifestations in different stages of HIV infection.
Acta oto-laryngologica. Supplementum 1991;481():515-21.
-
1990: Chamot E; Hirschel B; Wintsch J; Robert C F; Gabriel V; Déglon J J; Yerly S; Perrin L
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.
AIDS (London, England) 1990;4(12):1275-7.
-
1990: Robert C F; Déglon J J; Wintsch J; Martin J L; Perrin L; Bourquin M; Gabriel V; Hirschel B
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989.
AIDS (London, England) 1990;4(7):657-60.
-
1990: Hirschel B; Chopard P; Chave J P; Furrer H J; Opravil M; Hilti P; Vernazza P; Lazzarin A
Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS.
Medizinische Klinik (Munich, Germany : 1983) 1990;85 Suppl 2():268-70.
-
1989: D'Espine M; Bellido F; Pechère J C; Auckenthaler R; Rohner P; Lew D; Hirschel B
Serum levels of ciprofloxacin after single oral doses in patients with septicemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(12):1019-23.
-
1988: Calain P; Poolman J; Zollinger W; Sperber G; Bitter-Suermann D; Auckenthaler R; Hirschel B
Serological study of meningococcal isolates in Switzerland and France 1980-1986.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(6):788-91.
-
1988: Hirschel B
HIV infection: diagnosis and epidemiology.
Seminars in hematology 1988;25(3):197-207.
-
1987: Calain P; Krause K H; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
The Journal of infectious diseases 1987;155(2):187-91.
Sign-in to see more
